---
layout: post
title: "【图解年报】多瑞医药：2021年归母净利润为6851万元，同比下降25.5%"
date: 2022-03-24 20:56:19 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>多瑞医药于2022年3月25日披露年报，公司2021年实现营业总收入5.3亿，同比增长8.1%；实现归母净利润6850.8万，同比下降25.5%；每股收益为1.05元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2EDE406CAC46645F5BEF34CEFEF8A7F67_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D21171687F3AED3418439FD5F08026A31F_w800h400.jpg" alt=""><p><strong>期间费用为4亿，营业成本为6033.5万</strong></p><p>公司2021年营业成本6033.5万，同比增长35.9%，高于营业收入8.1%的增速，导致毛利率下降2.3%。期间费用率为75.3%，较去年下降1.2%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2EC18E73D49BCBA9D36A939C984BF5D3F_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203242322072442>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)